Delcath Systems Inc (DCTH)

[SAMNOTSAMUEL]

"For the year ended December 31, 2017, research and development expenses increased to $10.5 million from $8.4 million for the year ended December 31, 2016. The increase of $2.0 million is primarily due to the ongoing efforts of the FOCUS Trial which is discussed in further detail in the Current Clinical Development Program section above."

So offhand $10.5 million in 2017 for research and development. They would have spent more but NO vote limited the spending on research and development

The Queensbury facility is costly no doubt as well, but quality control of filter is important.

Where did that assessment on 10-K of yours come from. Cut and paste would be helpful